Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study - Marabelle, A; Le, DT; Ascierto, PA (J Clin Oncol, 2020)